4//SEC Filing
Hambleton Julie 4
Accession 0001415889-25-022042
CIK 0001496323other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:52 PM ET
Size
5.6 KB
Accession
0001415889-25-022042
Insider Transaction Report
Form 4
Hambleton Julie
Director
Transactions
- Disposition to Issuer
Common Stock
2025-08-14−2,000→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the "Company"), Concentra Biosciences, LLC, a Delaware limited liability company ("Parent"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), on August 14, 2025, Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a "CVR") subject to the terms and conditions of a Contingent Value Rights Agreement.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001578771
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:52 PM ET
- Size
- 5.6 KB